Kala Pharmaceuticals Inc • KALA

Capital at risk.

About Kala Pharmaceuticals Inc
Ticker
info
KALA
Trading on
info
NASDAQ
ISIN
info
US4831192020
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
-
Headquarters
info
1167 Massachusetts Avenue, Arlington, MA, United States, 02476
Employees
info
38
Website
info
kalarx.com
KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$7.6M
P/E ratio
info
-
EPS
info
-$5.64
Dividend Yield
info
0.00%
Beta
info
-2.49
Forward P/E ratio
info
0
EBIDTA
info
$-41.3M
Ex dividend date
info
-
Price & volume
Market cap
info
$7.6M
Average daily volume
info
19.8M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
0
Price to sales
info
1.16
Price to book
info
8.34
Earnings
EPS
info
-$5.64
EPS estimate (current quarter)
info
-$1.01
EPS estimate (next quarter)
info
-$0.32
EBITDA
info
$-41.3M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
-2.49
52-week High
info
$20.60
52-week Low
info
$0.61
50-day moving average
info
$2.41
200-day moving average
info
$5.62
Short ratio
info
0.94
Short %
info
7.68%
Management effectiveness
ROE (TTM)
info
-708.34%
ROA (TTM)
info
-65.81%
Profit margin
info
0.00%
Gross profit margin
info
$1.3M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
-100.00%
Share stats
Outstanding Shares
info
8.2M
Float
info
8.2M
Insiders %
info
1.86%
Institutions %
info
17.29%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$1.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$1.23
-$2.47
50.14%
Q4 • 24Beat
-$1.74
-$2.54
31.44%
Q1 • 25Beat
-$1.71
-$2.93
41.64%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-11.2M
-∞%
Q2 • 25
$0M
$-7.6M
-∞%
Q3 • 25
NaN%
-32.19%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$36.1M
$39.3M
108.89%
Q2 • 25
$25M
$1.1M
4.44%
Q3 • 25
-30.60%
-97.17%
-95.92%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-7.7M
$-0M
$-2.5M
$-7.7M
Q2 • 25
$-10.9M
$0M
$0M
$-10.9M
Q3 • 25
40.64%
-106.25%
-101.19%
40.43%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Kala Pharmaceuticals Inc share?
Collapse

Kala Pharmaceuticals Inc shares are currently traded for undefined per share.

How many shares does Kala Pharmaceuticals Inc have?
Collapse

Kala Pharmaceuticals Inc currently has 8.2M shares.

Does Kala Pharmaceuticals Inc pay dividends?
Collapse

No, Kala Pharmaceuticals Inc doesn't pay dividends.

What is Kala Pharmaceuticals Inc 52 week high?
Collapse

Kala Pharmaceuticals Inc 52 week high is $20.60.

What is Kala Pharmaceuticals Inc 52 week low?
Collapse

Kala Pharmaceuticals Inc 52 week low is $0.61.

What is the 200-day moving average of Kala Pharmaceuticals Inc?
Collapse

Kala Pharmaceuticals Inc 200-day moving average is $5.62.

Who is Kala Pharmaceuticals Inc CEO?
Collapse

The CEO of Kala Pharmaceuticals Inc is -.

How many employees Kala Pharmaceuticals Inc has?
Collapse

Kala Pharmaceuticals Inc has 38 employees.

What is the market cap of Kala Pharmaceuticals Inc?
Collapse

The market cap of Kala Pharmaceuticals Inc is $7.6M.

What is the P/E of Kala Pharmaceuticals Inc?
Collapse

The current P/E of Kala Pharmaceuticals Inc is null.

What is the EPS of Kala Pharmaceuticals Inc?
Collapse

The EPS of Kala Pharmaceuticals Inc is -$5.64.

What is the PEG Ratio of Kala Pharmaceuticals Inc?
Collapse

The PEG Ratio of Kala Pharmaceuticals Inc is 0.

What do analysts say about Kala Pharmaceuticals Inc?
Collapse

According to the analysts Kala Pharmaceuticals Inc is considered a buy.